Report

Lymphotoxin ß Receptor–Dependent Control of Lipid Homeostasis

+ See all authors and affiliations

Science  13 Apr 2007:
Vol. 316, Issue 5822, pp. 285-288
DOI: 10.1126/science.1137221

You are currently viewing the abstract.

View Full Text

Abstract

Hyperlipidemia, one of the most important risk factors for coronary heart disease, is often associated with inflammation. We identified lymphotoxin (LT) and LIGHT, tumor necrosis factor cytokine family members that are primarily expressed on lymphocytes, as critical regulators of key enzymes that control lipid metabolism. Dysregulation of LIGHT expression on T cells resulted in hypertriglyceridemia and hypercholesterolemia. In low-density lipoprotein receptor–deficient mice, which lack the ability to control lipid levels in the blood, inhibition of LT and LIGHT signaling with a soluble lymphotoxin β receptor decoy protein attenuated the dyslipidemia. These results suggest that the immune system directly influences lipid metabolism and that LT modulating agents may represent a novel therapeutic route for the treatment of dyslipidemia.

    View Full Text

    Related Content